SCHEMBL5104476

SCHEMBL5104476

NC(=O)C1CCN(c2ccccc2)C1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 1/20 0.51
PTPN1 P18031 1/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
HDAC8 Q9BY41 3/20 0.46
HDAC6 Q9UBN7 3/20 0.46
HDAC1 Q13547 1/20 0.46
ROCK2 O75116 1/20 0.46
ROCK1 Q13464 1/20 0.46
FPR1 P21462 1/20 0.45
FPR2 P25090 1/20 0.45
DDB1 Q16531 2/20 0.45
CRBN Q96SW2 2/20 0.45
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
CCNA2 P20248 1/20 0.44
CDK2 P24941 1/20 0.44
CCNA1 P78396 1/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL308869 0.86 PTPN1 (0.59) USP30PTPN1MEN1KMT2AHDAC8
SCHEMBL4477802 0.84 F10 (0.42) USP30PTPN1CCNA2CDK2CCNA1
SCHEMBL30697767 0.84 FPR2 (0.47) PTPN1MEN1KMT2AFPR1FPR2
SCHEMBL15374430 0.83 USP30 (0.51) USP30PTPN1MEN1KMT2AHDAC8
SCHEMBL14943747 0.83 USP30 (0.51) USP30PTPN1MEN1KMT2AHDAC8
SCHEMBL29009170 0.80 ALDH1A1 (0.53) MEN1KMT2AROCK2FPR2CCNA2
SCHEMBL11312660 0.80 USP30 (0.51) USP30PTPN1MEN1KMT2AHDAC8
SCHEMBL17321486 0.80 USP30 (0.48) USP30PTPN1MEN1KMT2AHDAC8
SCHEMBL12401311 0.80 USP30 (0.48) USP30PTPN1MEN1KMT2AHDAC8
SCHEMBL5585361 0.80 USP30 (0.57) USP30PTPN1MEN1KMT2AHDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104245675-B Cyclic amides as MetAP-2 inhibitors 默克专利股份公司 2017-10-13 CN claimed
US-7355053-B2 1-phenylpyrrolidine-2-one-3-carboxamides BASF AKTIENGESELLSCHAFT (DE) 2008-04-08 US claimed
US-20070004675-A1 Inhibitors of VEGF receptor and HGF receptor signaling METHYLGENE, INC. 2007-01-04 US claimed
US-20060019831-A1 1-phenylpyrrolidine-2-one-3-carboxamides BASF AKTIENGESELLSCHAFT (DE) 2006-01-26 US claimed
EP-1556346-A1 1-PHENYLPYRROLIDINE-2-ONE-3-CARBOXAMIDES BASF AKTIENGESELLSCHAFT (DE) 2005-07-27 EP claimed
WO-2004037787-A1 1-PHENYLPYRROLIDINE-2-ONE-3-CARBOXAMIDES BASF AKTIENGESELLSCHAFT (DE) 2004-05-06 WO claimed
CN-113620873-B Preparation method and application of zinc-containing binding group and quinoline skeleton compound 沈阳药科大学 2023-12-08 CN disclosed
EP-3663282-B1 PYRROLIDINONE HERBICIDES FMC CORP (US) 2022-05-18 EP disclosed
EP-3077374-B1 PYRROLIDINONES AS HERBICIDES FMC CORP (US) 2020-02-05 EP disclosed
WO-2013044361-A1 INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY METHYLGENE INC. (CA) 2013-04-04 WO disclosed
US-7355053-B2 1-phenylpyrrolidine-2-one-3-carboxamides BASF AKTIENGESELLSCHAFT (DE) 2008-04-08 US disclosed
US-7355053-B2 1-phenylpyrrolidine-2-one-3-carboxamides BASF AKTIENGESELLSCHAFT (DE) 2008-04-08 US disclosed
US-7355053-B2 1-phenylpyrrolidine-2-one-3-carboxamides BASF AKTIENGESELLSCHAFT (DE) 2008-04-08 US disclosed
US-20060019831-A1 1-phenylpyrrolidine-2-one-3-carboxamides BASF AKTIENGESELLSCHAFT (DE) 2006-01-26 US disclosed
US-20060019831-A1 1-phenylpyrrolidine-2-one-3-carboxamides BASF AKTIENGESELLSCHAFT (DE) 2006-01-26 US disclosed
US-20060019831-A1 1-phenylpyrrolidine-2-one-3-carboxamides BASF AKTIENGESELLSCHAFT (DE) 2006-01-26 US disclosed
EP-1556346-A1 1-PHENYLPYRROLIDINE-2-ONE-3-CARBOXAMIDES BASF AKTIENGESELLSCHAFT (DE) 2005-07-27 EP disclosed
EP-1556346-A1 1-PHENYLPYRROLIDINE-2-ONE-3-CARBOXAMIDES BASF AKTIENGESELLSCHAFT (DE) 2005-07-27 EP disclosed
WO-2004037787-A1 1-PHENYLPYRROLIDINE-2-ONE-3-CARBOXAMIDES BASF AKTIENGESELLSCHAFT (DE) 2004-05-06 WO disclosed
WO-2004037787-A1 1-PHENYLPYRROLIDINE-2-ONE-3-CARBOXAMIDES BASF AKTIENGESELLSCHAFT (DE) 2004-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004675-A1 Inhibitors of VEGF receptor and HGF receptor signaling HGF, MET, FLT1 USP30 3430/4885PTPN1 911/4885MEN1 3655/4885
US-20060019831-A1 1-phenylpyrrolidine-2-one-3-carboxamides RXFP1, REN, NPY1R USP30 4247/4885PTPN1 371/4885MEN1 4396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.